Fig. 2From: Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cyclesComparisons of survival outcomes in the subgroup of patients who did not receive secondary debulking surgery. a Progression-free survival; b Overall survivalBack to article page